Perfluorocarbon liquid: its application in vitreoretinal surgery and related ocular inflammation

Qi Yu, Kun Liu, Li Su, Xin Xia, Xun Xu, Qi Yu, Kun Liu, Li Su, Xin Xia, Xun Xu

Abstract

The application of perfluorocarbon liquids has been well acclaimed in vitreoretinal surgery. Its unique physical properties make it an ideal intraoperative tool to improve the efficiency and safety of surgical procedures in complicated cases. The main functions of perfluorocarbon liquids in vitreoretinal surgery include relocating and fixing the detached retina, displacing the subretinal and subchoroidal to fluid anteriorly, revealing proliferative vitreous retinopathy (PVR) for further maneuvers, protecting the macula from exposure to chemicals with potential toxicity, and assisting the removal of foreign body. The related clinical applications include retinal detachment with severe proliferative vitreoretinopathy, giant tear, diabetic retinopathy (DR), retinopathy of prematurity (ROP), and posterior dislocated crystalline and intraocular lenses. The application of perfluorocarbon liquids has been expended over the past fewer years. Several PFCLs related ocular inflammations have been observed in in vitro studies, animal studies, and clinical follow-up. The complete removal of PFCLs is recommended at the end of the surgery in most cases.

References

    1. Chang S. Perfluorocarbon liquids in vitreoretinal surgery. International Ophthalmology Clinics. 1992;32(2):153–163.
    1. Organofluorine Chemistry: Principles and Commercial Applications. Springer; 1994.
    1. Joussen AM, Wong D. The concept of heavy tamponades—chances and limitations. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2008;246(9):1217–1224.
    1. Peyman GA, Schulman JA, Sullivan B. Perfluorocarbon liquids in ophthalmology. Survey of Ophthalmology. 1995;39(5):375–395.
    1. Berrocal MH, Chang S. Perfluorocarbon liquids in vitreous surgery. Ophthalmology Clinics of North America. 1994;7:67–76.
    1. Velikay M, Wedrich A, Stolba U, Datlinger P, Li Y, Binder S. Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin. American Journal of Ophthalmology. 1993;116(5):565–570.
    1. Sargent JW, Seffl RJ. Properties of perfluorinated liquids. Federation Proceedings. 1970;29(5):1699–1703.
    1. Sparrow JR, Jayakumar A, Berrocal M, Ozmert E, Chang S. Experimental studies of the combined use of vitreous substitutes of high and low specific gravity. Retina. 1992;12(2):134–140.
    1. Georgalas I, Ladas I, Tservakis I, et al. Perfluorocarbon liquids in vitreoretinal surgery: a review of applications and toxicity. Cutaneous and Ocular Toxicology. 2011;30(4):251–262.
    1. Drury B, Bourke RD. Short-term intraocular tamponade with perfluorocarbon heavy liquid. British Journal of Ophthalmology. 2011;95(5):694–698.
    1. Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. American Journal of Ophthalmology. 1987;103(1):38–43.
    1. Clark LC, Jr., Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 1966;152(3730):1755–1756.
    1. Shaffer TH, Wolfson MR, Clark LC., Jr. Liquid ventilation. Pediatric Pulmonology. 1992;14(2):102–109.
    1. Haidt SJ, Clark LC, Ginsberg J. Liquid perfluorocarbon replacement in the eye. Investigative Ophthalmology & Visual Science. 1982;22, article 233
    1. Zimmerman NJ, Faris D. The use of N-perfluorocarbon amines in complicated retinal detachments. Investigative Ophthalmology & Visual Science. 1984;25, supplement, article 258
    1. Chang S, Ozmert E, Zimmerman NJ. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. American Journal of Ophthalmology. 1988;106(6):668–674.
    1. Stolba U, Binder S, Velikay M, Datlinger P, Wedrich A. Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications. British Journal of Ophthalmology. 1995;79(12):1106–1110.
    1. Carroll BF, Peyman GA, Mehta NJ, et al. Repair of retinal detachment associated with proliferative vitreoretinopathy using perfluoroperhydrophenanthrene (Vitreon) Canadian Journal of Ophthalmology. 1994;29(2):66–69.
    1. Coll GE, Chang S, Sun J, Wieland MR, Berrocal MH, Capone A., Jr. Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1995;102(4):630–639.
    1. Greve MDJ, Peyman GA, Millsap CM. Relaxing retinotomy under perfluorocarbon liquid. Ophthalmic Surgery and Lasers. 1996;27(2):154–155.
    1. Ambresin A, Wolfensberger TJ, Bovey EH. Management of giant retinal tears with vitrectomy, internal tamponade, and peripheral 360° retinal photocoagulation. Retina. 2003;23(5):622–628.
    1. Mathis A, Pagot V, Gazagne C, Malecaze F. Giant retinal tears: Surgical techniques and results using perfluorodecalin and silicone oil tamponade. Retina. 1992;12(3):S7–S10.
    1. Chang S, Lincoff H, Zimmerman NJ, Fuchs W. Giant retinal tears. Surgical techniques and result using perfluorocarbon liquids. Archives of Ophthalmology. 1989;107(5):761–766.
    1. Zhioua R, Malek I, Kria L, Ouertani A. Retinal detachment associated with giant retinal tear: surgical procedures and results of the perfluorocarbon liquid-silicone oil exchange with scleral buckling. Journal Francais d’Ophtalmologie. 2005;28(4):366–370.
    1. Scott IU, Murray TG, Flynn HW, Jr., Feuer WJ, Schiffman JC. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmology. 2002;109(10):1828–1833.
    1. Kertes PJ, Wafapoor H, Peyman GA, Calixto N. J, Thompson H. The management of giant retinal tears using perfluoroperhydrophenanthrene: a multicenter case series. Ophthalmology. 1997;104(7):1159–1165.
    1. Xu X, Zhang X, Wu N, Ho PCP. Treatment of early giant retinal tears with domestic perfluorodecalin and perfluoropropane. Chinese Medical Journal. 1999;112(3):211–213.
    1. Smiddy WE, Flynn HW., Jr. Vitrectomy in the management of diabetic retinopathy. Survey of Ophthalmology. 1999;43(6):491–507.
    1. Imamura Y, Minami M, Ueki M, Satoh B, Ikeda T. Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy. British Journal of Ophthalmology. 2003;87(5):563–566.
    1. Millsap CM, Peyman GA, Ma PE, Greve MDJ. The surgical management of retinopathy of prematurity using a perfluorocarbon liquid. International Ophthalmology. 1994;18(2):97–100.
    1. Imaizumi A, Kusaka S, Noguchi H, et al. Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment. American Journal of Ophthalmology. 2014;157(2):384.e2–389.e2.
    1. Chang S, Reppucci V, Zimmerman NJ, Heinemann M-H, Coleman DJ. Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology. 1989;96(6):785–792.
    1. Desai UR, Peyman GA, Harper CA., III Perfluorocarbon liquid in traumatic vitreous hemorrhage and retinal detachment. Ophthalmic Surgery. 1993;24(8):537–541.
    1. Movshovich A, Berrocal M, Chang S. The protective properties of liquid perfluorocarbons in phacofragmentation of dislocated lenses. Retina. 1994;14(5):457–462.
    1. Millar ERA, Steel DHW. Small-gauge transconjunctival vitrectomy with phacoemulsification in the pupillary plane of dense retained lens matter on perfluorocarbon liquids after complicated cataract surgery. Graefe’S Archive for Clinical and Experimental Ophthalmology. 2013;251(7):1757–1762.
    1. Dalma-Weiszhausz J, Franco-Cardenas V, Dalma A. A modified technique for extracting a dislocated lens with perfluorocarbon liquids and viscoelastics. Ophthalmic Surgery Lasers and Imaging. 2010;41(5):572–574.
    1. Jang HD, Lee SJ, Park JM. Phacoemulsification with perfluorocarbon liquid using a 23-gauge transconjunctival sutureless vitrectomy for the management of dislocated crystalline lenses. Graefe’S Archive for Clinical and Experimental Ophthalmology. 2013;251(5):1267–1272.
    1. Nishimura A, Kita K, Segawa Y, Shirao Y. Perfluorocarbon liquid assists in stripping the ILM to treat detached retina caused by macular hole. Ophthalmic Surgery and Lasers. 2002;33(1):77–78.
    1. Rizzo S, Belting C, Genovesi-Ebert F, Vento A, Cresti F. Modified technique for safer indocyanine-green-assisted peeling of the internal limiting membrane during vitrectomy for macular hole repair. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2006;244(12):1615–1619.
    1. Brazitikos PD, Androudi S, Dimitrakos SA, Stangos NT. Removal of the internal limiting membrane under perfluorocarbon liquid to treat macular-hole-associated retinal detachment. American Journal of Ophthalmology. 2003;135(6):894–896.
    1. Lee SC, Lee I, Koh HJ, Kim SH, Kwon OW. Massive suprachoroidal hemorrhage with retinal and vitreous incarceration; a vitreoretinal surgical approach. Korean Journal of Ophthalmology. 2000;14(1):41–44.
    1. Desai UR, Peyman GA, Chen CJ, et al. Use of perfluoroperhydrophenanthrene in the management of suprachoroidal hemorrhages. Ophthalmology. 1992;99(10):1542–1547.
    1. Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. American Journal of Ophthalmology. 1996;121(3):267–275.
    1. Jonas JB, Jäger M. Perfluorohexyloctane endotamponade for treatment of subfoveal hemorrhage. European Journal of Ophthalmology. 2002;12(6):534–536.
    1. Inoue M, Iriyama A, Kadonosono K, Tamaki Y, Yanagi Y. Effects of perfluorocarbon liquids and silicone oil on human retinal pigment epithelial cells and retinal ganglion cells. Retina. 2009;29(5):677–681.
    1. Osterholz J, Winter M, Winkler J, et al. Retinal damage by perfluorocarbon liquids—a question of specific gravity? Intraocular pressure peaks and shearing forces. Klinische Monatsblatter fur Augenheilkunde. 2009;226(1):38–47.
    1. Mackiewicz J, Maaijwee K, Lüke C, et al. Effect of gravity in long-term vitreous tamponade: in vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2007;245(5):665–675.
    1. Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R. Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina. 1991;11(4):367–374.
    1. Elsing SH, Fekrat S, Green WR, Chang S, Wajer SD, Haller JA. Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid. Ophthalmology. 2001;108(1):45–48.
    1. Singh J, Ramaesh K, Wharton SB, Cormack G, Chawla HB. Perfluorodecalin-induced intravitreal inflammation. Retina. 2001;21(3):247–251.
    1. Sparrow JR, Ortiz R, MacLeish PR, Chang S. Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone, and fluorosilicone liquids. Investigative Ophthalmology and Visual Science. 1990;31(4):638–646.
    1. Zeana D, Becker J, Kuckelkorn R, Kirchhof B. Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. International Ophthalmology. 1999;23(1):17–24.
    1. Veckeneer MA, Voogd S, Lindstedt EW, Menz D-H, Meurs JC. An epidemic of sticky silicone oil at the Rotterdam Eye Hospital. Patient review and chemical analyses. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2008;246(6):917–922.
    1. Velikay M, Stolba U, Wedrich A, Li Y, Datlinger P, Binder S. The effect of chemical stability and purification of perfluorocarbon liquids in experimental extended-term vitreous substitution. Graefe’s Archive for Clinical and Experimental Ophthalmology. 1995;233(1):26–30.
    1. Lesnoni G, Rossi T, Gelso A. Subfoveal liquid perfluorocarbon. Retina. 2004;24(1):172–176.
    1. Garcia-Valenzuela E, Ito Y, Abrams GW. Risk factors for retention of subretinal perfluorocarbon liquid in vitreoretinal surgery. Retina. 2004;24(5):746–752.
    1. Cohen SY, Dubois L, Elmaleh C. Retinal hole as a complication of long-standing subretinal perfluorocarbon liquid. Retina. 2006;26(7):843–844.
    1. Sakurai E, Ogura Y. Removal of residual subfoveal perfluoro-n-octane liquid. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2007;245(7):1063–1064.
    1. Berglin L, Ren J, Algvere PV. Retinal detachment and degeneration in response to subretinal perfluorodecalin in rabbit eyes. Graefe’s Archive for Clinical and Experimental Ophthalmology. 1993;231(4):233–237.
    1. Romano MR, Vallejo-Garcia JL, Parmeggiani F, et al. Interaction between perfluorcarbon liquid and heavy silicone oil: risk factor for “Sticky Oil” formation. Current Eye Research. 2012;37(7):563–566.
    1. Quiroz-Mercado H, Garcia-Aguirre G, Ustáriz-González O, Martín-Avià J, Martinez-Jardon S. Perfluorocarbon-perfused vitrectomy using a transconjunctival 25-gauge system. Retina. 2007;27(7):926–931.
    1. Quiroz-Mercado H, Suarez-Tatá L, Magdalenic R, et al. Perfluorocarbon perfused vitrectomy: Animal Studies. American Journal of Ophthalmology. 2004;137(2):287–293.
    1. Quiroz-Mercado H, Guerrero-Naranjo J, Agurto-Rivera R, et al. Perfluorocarbon-perfused vitrectomy: a new method for vitrectomy—A Safety and Feasibility Study. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2005;243(6):551–562.
    1. Quiroz-Mercado H, Rivera-Sempertegui J, MacKy TA, et al. Performing vitreous biopsy by perfluorocarbon-perfused vitrectomy. American Journal of Ophthalmology. 2005;140(6):1161–1163.
    1. Arevalo JF. En bloc perfluorodissection in vitreoretinal surgery: a new surgical technique. Retina. 2008;28(4):653–656.
    1. Wang Z-Y, Zhao K-K, Zhao D-S, Zhao P-Q. Dissection under perfluorocarbon liquid: a modified vitrectomy technique for diabetic tractional retinal detachment. Retina. 2012;32(4):848–852.
    1. Kobuch K, Menz DH, Hoerauf H, Dresp JH, Gabel V-P. New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2001;239(9):635–642.
    1. Martinez-Reina MJ, Ruiz-Moreno JM, Montero JA, Rueda J. Histopathology and ultrastructure of rabbit retina after intravitreous injection of perfluorohexyloctane (F6H8) Current Eye Research. 2005;30(9):773–779.
    1. Sorcinelli R, Lai ML. Unusual complication after temporary use of perfluorohexyloctane (F 6H8) in the treatment of complicated retinal detachment. Retina. 2005;25(1):89–90.
    1. Schatz B, El-Shabrawi Y, Haas A, Langmann G. Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgery. Retina. 2004;24(4):567–573.
    1. Wagenfeld L, Zeitz O, Skevas C, Richard G. Long-lasting endotamponades in vitreoretinal surgery. Ophthalmologica. 2010;224(5):291–300.
    1. Tognetto D, Lepori L, Lapasin R, et al. A new heavy internal tamponade in vitreoretinal surgery: An in Vitro Study. Eye. 2008;22(8):1082–1088.
    1. Wong D, Van Meurs JC, Stappler T, et al. A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. British Journal of Ophthalmology. 2005;89(6):662–665.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner